SESSION 71 SCHEDULE
Friday
SESSION 71: UPDATED OR NEW CAROTID ASSESSMENT TECHNIQUES, TECHNOLOGY OR CONCEPTS
x
ASSESSMENT OF CAROTID PLAQUE RISK
6:40 AM - 6:45 AM Progress In Non-Invasive Prediction Of High Risk Asymptomatic Carotid Plaques Using Bio-Optical Imaging To Detect Macrophage Infiltration And MMPs
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
6:46 AM - 6:51 AM Use Of Web-Based Platforms And Features Of The Arterial Wall For Risk Stratification Of Asymptomatic Carotid Plaques: Can These Features And Risks Be Modified By Statins
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM Can We Identify The Small Percentage Of ACS Patients Who May Benefit From CEA Or CAS: What Is That Percentage
  Presenter(s):Henrik Sillesen, MD, DMSc  
6:58 AM - 7:03 AM Assessment Of Carotid Plaque Embolic Risk With 3D MRI: Correlation With TCD And Diffusion Weighted Brain MRI
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
7:04 AM - 7:09 AM How Plaque Morphological Studies Can Resolve The Controversy Regarding Treatment Of Patients With Asymptomatic Carotid Stenosis (ACS) And Which Patients Should Undergo Invasive Treatment
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
  View Slides in PDF      
7:10 AM - 7:15 AM Carotid Interventions Should Not Be Based On Consensus Duplex Velocity Criteria: More Stringent Criteria Can Reduce Unnecessary Procedures And Show The Value Of Interventions In CREST 2
  Presenter(s):Mark F. Fillinger, MD  
  View Slides in PDF      
7:16 AM - 7:21 AM Pitfalls In The Sole Use Of Duplex Scans In Decision Making For Treatment Of Carotid Lesions
  Presenter(s):Glenn M. LaMuraglia, MD / Richard P. Cambria, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM What Is The Significance Of Asymptomatic Emboli During Carotid Procedures: They Cannot Be Good
  Presenter(s):Mark H. Wholey, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM How Can Asymptomatic Carotid Stenosis Progression Be Predicted And How Can It Help Clinical Decision Making
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
7:34 AM - 7:39 AM Current Status Of Methods To Reliably And Non-Invasively Detect Asymptomatic Plaques At A High Risk Of Causing A Stroke
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
7:40 AM - 7:45 AM Panel Discussion
END OF SESSION 71
 
SESSION 72 SCHEDULE
Friday
SESSION 72: SPINAL CORD ISCHEMIA (SCI) WITH TAAA AND THORACIC ANEURYSM (TAA) REPAIRS; ITS PATHOGENESIS, PREVENTION AND TREATMENT
x
7:46 AM - 7:51 AM Critical Review Of Spinal Cord Protection From SCI In TAAAs – Open And Endo: Current Concepts And Future Prospects
  Presenter(s):Christian D. Etz, MD, PhD  
  View Slides in PDF      
7:52 AM - 7:57 AM The 4-Territory Hypothesis For Risk Stratification In SCI And How It Can Help In Prophylaxis And Treatment Of SCI With Thoracic Aortic Procedures
  Presenter(s):Martin Czerny, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM New Concepts In Paraplegia After TEVAR: What Role Does Spinal Cord Edema Play, What Causes It And How Can It Be Prevented
  Presenter(s):Hamdy Awad, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Mechanisms Of SCI In Open TAAA Repair And F/BEVAR: How Do They Differ And How Should Prevention And Management Differ
  Presenter(s):Charles W. Acher, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM Update On Prevention And Consequences Of SCI During Open And Endo TAAA And TAA Repairs: What Is Different Between Open And Endo Procedures And Treatment
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Motor Evoked Potentials (MEPs) As An Indicator For Selective Staging Of B/FEVARs And TAAA Repairs: Technique And Results
  Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM Relevance Of MEPs In Endovascular TAAA Repairs And Strategies To Decrease Paraplegia
  Presenter(s):Piotr M. Kasprzak, MD  
  View Slides in PDF      
8:28 AM - 8:33 AM Value Of Intrathecal Papaverine In Decreasing SCI And Paraplegia With Complex TAA And TAAA Repairs
  Presenter(s):Eric E. Roselli, MD / Lars G. Svensson, MD, PhD  
  View Slides in PDF      
8:34 AM - 8:39 AM Technique And Limits Of Spinal Drainage With TAA And TAAA Repairs: How To Prevent Spinal Drain Complications
  Presenter(s):Mark A. Farber, MD / Anthony L. Estrera, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM The Real Truth About The Incidence And Consequences Of SCI After Open And Endo TAAA Repair: Methods Of Prevention
  Presenter(s):Nicholas J.W. Cheshire, MD  
  View Slides in PDF      
8:46 AM - 8:51 AM Remote Ischemic Pre-Conditioning: What Is It And Can It Protect Against SCI
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
8:52 AM - 9:00 AM Panel Discussion
9:00 AM - 9:12 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 72
 
SESSION 73 SCHEDULE
Friday
SESSION 73: CAROTID RELATED TOPICS
x
9:12 AM - 9:17 AM Emergency CEA For A Stroke In Evolution: When Is It Indicated And How Should It Be Performed
  Presenter(s):Afshin Assadian, MD / Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
TOPICS RELATED TO COGNITIVE CHANGES
9:18 AM - 9:23 AM Size Of Embolic Particles Released During CAS Matters And Correlates With Neuro-Cognitive Deterioration After The Procedure
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
9:24 AM - 9:29 AM Effect Of Carotid Interventions On Cognition: Does CAS/CEA Improve Or Worsen Cognitive Function: Cognitive Tests Should Be An Outcome Measures For CAS And CEA
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
9:30 AM - 9:35 AM Prospective Comparison Of Neuropsychologic Outcomes After CEA And Protected CAS (TCAR): Despite An Increase In Emboli And DW MRI Lesions With CAS, No Differences Were Noted On Testing
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
  View Slides in PDF      
9:36 AM - 9:41 AM Comparison Of Left Carotid Subclavian Bypass And Transposition: Pros And Cons Of Each For Primary Subclavian Disease And With TEVAR
  Presenter(s):Mark K. Eskandari, MD  
  View Slides in PDF      
9:42 AM - 9:47 AM Proper Technique For Subclavian To Carotid Artery Transposition
  Presenter(s):Mark D. Morasch, MD, FACS, RPVI / Ramon Berguer, MD, PhD  
  View Slides in PDF      
9:48 AM - 9:53 AM Fate Of Non-Operated False Aneurysms After Acute Carotid Dissections: How Should They Be Managed
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
9:54 AM - 9:59 AM Management Of Carotid Patch Infection With And Without False Aneurysms: Proving Infection Can Be Hard – How To Do It
  Presenter(s):Patrick A. Stone, MD / Ali F. AbuRahma, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM Systematic Review Of Stroke And Death Rates After CAS And CEA In 21 Contemporary Big Registries: These Adverse Event Rates Are Higher Than Expected From RCTs: In Symptomatic And Asymptomatic Patients
  Presenter(s):Ross Naylor, MD, FRCS / Kosmas I. Paraskevas, MD  
  View Slides in PDF      
10:06 AM - 10:11 AM Use Of Covered Stents (Stent-Grafts) For Carotid Artery Injuries, Patch And Tumor False Aneurysms And Blowouts: How To Use Them Safely And Long-Term Results
  Presenter(s):Michael B. Silva, Jr., MD  
  View Slides in PDF      
10:12 AM - 10:20 AM Panel Discussion
END OF SESSION 73
 
SESSION 74 SCHEDULE
Friday
SESSION 74: MORE HOT CAROTID RELATED TOPICS; FLAWED GUIDELINES; IMPACT OF MEDICAL THERAPY, CAS AND CEA; STROKE PREDICTION
x
10:20 AM - 10:25 AM What Is Wrong With Current Carotid Guidelines: How Important Is Bias: What Would An Evidence-Based Carotid Guideline Look Like
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
10:26 AM - 10:31 AM How Low Do Statins Have To Go To Drive LDL-C To Produce Carotid Plaque Regression And Improved Echogenicity; Value Of Ezetimibe In Getting There And Of 3D Ultrasound In Detecting Regression
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
10:32 AM - 10:37 AM Contralateral ICA Occlusion Is A Major Stroke/Death Risk Factor For CEA But Not For CAS: Single Center And A Meta-Analysis Show It
  Presenter(s):Gianluca Faggioli, MD / Andrea Stella, MD / Mauro Gargiulo, MD  
  View Slides in PDF      
10:38 AM - 10:43 AM New Developments In Transcranial Doppler (TCD) Testing: How It Can Help In Everyday Clinical Practice
  Presenter(s):Zsolt Garami, MD  
  View Slides in PDF      
10:44 AM - 10:49 AM Endovascular ICA Occlusion After Intracranial Thrombus Removal In Patients With Tandem (Intracranial And Extracranial Lesions) To Prevent Further Intracranial Embolization And Second Strokes: Advantages, Precautions And Limitations
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
10:50 AM - 10:55 AM Decrease In Mental Acuity, DW MRI Lesions And Cranial Nerve Injuries Should Be Outcome Measures (End Points) In Comparisons Of CAS And CEA
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
  View Slides in PDF      
10:56 AM - 11:01 AM Impact Of Post-Procedural TIAs On Long-Term Survival After CAS And CEA: TIAs Are Not Innocuous
  Presenter(s):Andrea Stella, MD / Gianluca Faggioli, MD  
  View Slides in PDF      
11:02 AM - 11:10 AM Panel Discussion
Moderator(s): Frank J. Veith, MD / Ross Naylor, MD, FRCS  
11:10 AM - 11:15 AM What Are Predictors Of Bad Outcomes After CAS; After CEA: They Are Not The Same
  Presenter(s):Kim J. Hodgson, MD  
  View Slides in PDF      
11:16 AM - 11:21 AM Anatomical And Technical Predictors Of Stroke And Death After CAS
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
11:22 AM - 11:27 AM Mechanisms Of Procedural Strokes In The ICSS And ACST I Trials: What Are The Practice Implications And What Is The Value Of Troponins In Patients Undergoing CEA Or CAS
  Presenter(s):Gert J. de Borst, MD  
  View Slides in PDF      
11:28 AM - 11:33 AM Clinical And Procedural Variables That Modify The Risk Of Stroke, MI And Death After CEA And CAS In Symptomatic Carotid Stenosis Patients: What Can Be Done To Lower These Risks
  Presenter(s):Afshin Assadian, MD / Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
11:34 AM - 11:39 AM What Is The Current Gold Standard Of Cerebral Protection With CAS
  Presenter(s):Giancarlo Biamino, MD, PhD  
  View Slides in PDF      
11:40 AM - 11:45 AM When Can A Mini-Incision (1.5 inches – 4 cm) CEA Be Performed With Or Without A Shunt: Tips And Tricks To Do It Safely
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
11:46 AM - 11:51 AM Diaphragm Of The ICA: An Underdiagnosed Cause Of Recurrent Stroke: How Can It Best Be Diagnosed And Treated
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 74
 
SESSION 75 SCHEDULE
Friday
SESSION 75: MORE CAROTID DISEASE AND TREATMENT RELATED TOPICS AND CONTROVERSIES; TRANSCERVICAL CAS (TCAR) AND NEW MESH COVERED CAROTID STENTS
x
1:00 PM - 1:05 PM Midterm Results Of The ROADSTER PIVOTAL Trial Of The Silk Road System For TransCarotid Artery Stent Revascularization (TCAR) In High Risk Patients With Carotid Stenosis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Christopher J. Kwolek, MD / Richard P. Cambria, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM New Developments In The Silk Road System For TCAR: Details And Improvements In The Enroute System For CAS: How It Works And Achieves Flow Reversal Embolic Protection: Indications, Contraindications And Learning Curve Issues
  Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Early Results Of The ROADSTER 2 Post-Market Registry Of TCAR In Normal Risk And High Risk Patients With Carotid Stenosis
  Presenter(s):Vikram S. Kashyap, MD / Peter A. Schneider, MD  
  View Slides in PDF      
MEGA DEBATE ON TIMING AFTER SYMPTOM ONSET
1:18 PM - 1:23 PM DEBATE: Early CEA After Symptom Onset Is Beneficial To Patients: The Earlier The Better After Certain Requirements Are Met
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
1:24 PM - 1:29 PM DEBATE: Early CEA After Symptoms (TIA Or Small Stroke): Timing Is Everything: Within 48 Hours Is Bad: Within 3-14 Days Is Good: Why
  Presenter(s):Ian Loftus, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM DEBATE: Early CEA (Within 48 Hours) After TIA Or Stroke: A Balanced View: What Are The Risks And Benefits: Early Brain Imaging And Carotid Duplex Can Help Select Patients For Safe, Early Intervention
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM DEBATE: Another Balanced View: When Is Early CEA After Symptom Onset In Patients With Carotid Stenosis Safe And Beneficial And When Is It Not
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
NEW MESH COVERED CAROTID STENTS
1:42 PM - 1:47 PM Comparison Of 3 Micromesh Covered Stents For CAS: Indications For Each And > 1-Year Clinical Results
  Presenter(s):Piotr Musialek, MD, DPhil / Max Amor, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Impact Of TCAR And Micro-Mesh Stent Usage With The C-Guard Stent (Inspire MD) On CAS: Do They Decrease DW MRI Cerebral Embolic Lesions: Which Helps Most
  Presenter(s):Piotr Musialek, MD, DPhil / Mariusz Trystula, MD, PhD  
  View Slides in PDF      
1:54 PM - 1:59 PM Dual Layer Micromesh Stents Decrease New Ischemic Brain Lesions After CAS: What Is The Functional Significance And Will These Micromesh Stents Have Downsides
  Presenter(s):Maria Antonella Ruffino, MD, EBIR  
  View Slides in PDF      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 75
 
SESSION 76 SCHEDULE
Friday
SESSION 76: LATE BREAKING INFORMATION AND TRIAL STATUS RELATED TO CAROTID DISEASE AND ITS TREATMENT: CREST 2, ECST 2 AND ACST 2 STATUS AND ISSUES
x
CREST 2 RELATED TOPICS
2:06 PM - 2:11 PM Where Do We Stand With CREST 2 And What Will It Tell Us
  Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Will CREST 2 Incorporate Recent Advances In CAS (Cervical Access, Reversal Of Flow And Mesh Covered Stents) And What Will It Tell Us
  Presenter(s):L. Nelson Hopkins, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM CREST 2 May Change Little Or Nothing In Carotid Treatment Practice: Why Is This So
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
2:24 PM - 2:29 PM Why CREST 2 May Tell Us Very Little But Still Be Bad For Carotid Stenting (CAS)
  Presenter(s):Mark H. Wholey, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Barriers To Enrollment In CREST 2: How Can They Be Overcome
  Presenter(s):Mark Conrad, MD, MMSc  
  View Slides in PDF      
2:36 PM - 2:41 PM History Of Transcervical CAS And How To Do It With Standard Equipment
  Presenter(s):Enrique Criado, MD, FACS  
  View Slides in PDF      
2:42 PM - 2:48 PM Panel Discussion
Moderator(s): L. Nelson Hopkins, MD / Max Amor, MD  
2:48 PM - 2:53 PM New Findings From CREST 1: Relationship Between Plaque Morphology And Post-Procedural Neurologic Events: Which Plaques Are High Risk For CAS But Not For CEA
  Presenter(s):Wesley S. Moore, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Update On The ECST 2 Trial: What Is It Telling Us Relevant To Carotid Lesion Treatment
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD / Leo H. Bonati, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Update On The ACST 2 Trial Comparing CAS And CEA In Asymptomatic Patients: Lessons Learned To Date
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
  View Slides in PDF      
3:06 PM - 3:11 PM Current Optimal Management Of Radiation Carotid Stenosis: Risk Of CEA And CAS And Which Is The Best Treatment For Symptomatic And Asymptomatic Disease In This Setting
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
3:12 PM - 3:17 PM International Variability In Carotid And AAA Treatment: Highlights From The International Consortium Of Vascular Registries
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
3:18 PM - 3:24 PM Panel Discussion
3:24 PM - 3:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 76
 
SESSION 77 SCHEDULE
Friday
SESSION 77: NEW CAROTID CONCEPTS AND UPDATES
x
3:36 PM - 3:41 PM Carotid Pseudo-Occlusions: How Are They Best Diagnosed And Treated: What Are The Results Of Treatment And No Treatment
  Presenter(s):Sonia Ronchey, MD, PhD  
  View Slides in PDF      
3:42 PM - 3:47 PM Spontaneous Recanalization Of An Occluded Internal Carotid Artery (ICA): What Is The Clinical Significance
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
  View Slides in PDF      
3:48 PM - 3:53 PM Carotid Bypass With Gore Hybrid Graft As A Rescue Method For CEA Gone Bad During The Operation: Technique And 1-Year Results
  Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS  
  View Slides in PDF      
3:54 PM - 3:59 PM Contemporary Population-Based Outcomes For CAS And CEA: From The SVS Registry: How Do We Know The Data Are Accurate
  Presenter(s):Joseph J. Ricotta II, MD, MS  
  View Slides in PDF      
4:00 PM - 4:05 PM Comparison Of Mesh Covered C-Guard Stent vs. Wallstent For CAS: DW MRI And Clinical Results Show Benefit Of Mesh Covered Stent
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
4:06 PM - 4:11 PM Are There Clinical Advantages Of Micromesh Covered And Dual Layer Stent Designs Over Closed Cell Stents In CAS
  Presenter(s):Stefan Müller-Hülsbeck, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM DEBATE: CAS Has No Increased Cost Consequences Compared To CEA
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM DEBATE: Not So: CEA Costs Less Than CAS: Why The Discrepancy
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Slides in PDF      
4:24 PM - 4:29 PM Carotid Webs Can Cause Strokes: How Should They Be Diagnosed And Treated: Should They Be Treated If Asymptomatic
  Presenter(s):Evan C. Lipsitz, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Current Status Of Surgery For Carotid Body Tumors: What Is New With Techniques And Adjuncts
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
4:36 PM - 4:42 PM Panel Discussion
END OF SESSION 77
 
SESSION 78 SCHEDULE
Friday
SESSION 78: NEW CONCEPTS AND UPDATES RELATED TO PERCUTANEOUS EVAR (PEVAR), WOUND CARE, SYMPATHECTOMY, MULTIPLE ANEURYSMS, ENDOVASCULAR NARROWING AND BRIDGING ANTICOAGULATION
x
UPDATE ON PEVAR
4:42 PM - 4:47 PM New Developments And Devices For PEVAR: What Is On The Horizon – Especially For Large Bore Sheaths
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Slides in PDF      
4:48 PM - 4:53 PM Percutaneous EVAR (PEVAR) vs. Open Surgical Access For EVAR: A Single Center RCT And The Multicenter PIERO RCT: An Overview Of Cost Effectiveness And Complications Of Both Procedures
  Presenter(s):Afshin Assadian, MD / Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
4:54 PM - 4:59 PM How To Perform PEVAR: Tips And Tricks (Video Presentation)
  Presenter(s):Zoran Rancic, MD, PhD  
  View Slides in PDF      
5:00 PM - 5:05 PM Update On Fascial Suture Closure For PEVAR: Safety, Technical Tips And How It Saves Time And Money
  Presenter(s):Thomas Larzon, MD, PhD  
  View Slides in PDF      
5:06 PM - 5:11 PM Large Sheath Closure With The Proglide Device: Tips, Tricks And Economic Value
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
5:12 PM - 5:17 PM Cost Implications Of PEVAR: How Can It Be Made Cost Effective
  Presenter(s):Maciej L. Dryjski , MD, PhD  
  View Slides in PDF      
OTHER NEW CONCEPTS
5:18 PM - 5:23 PM What’s New In Wound Care In PAD, The Diabetic Foot And Combined Arterial And Venous Ulcerations
  Presenter(s):Katherine A. Gallagher, MD  
  View Slides in PDF      
5:24 PM - 5:29 PM Renaissance For Chemical Sympathectomy In A Vascular Practice: Indications, Techniques And Results
  Presenter(s):Donald B. Reid, MD  
  View Slides in PDF      
5:30 PM - 5:35 PM Multifocal Synchronous Aorto-Iliac Femoro-Popliteal Aneurysms: Sequence And Strategies For Access And Treatment: Does It Depend On Aneurysm Size
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
5:36 PM - 5:41 PM Onion Skin And Other Techniques For Decreasing, In A Controlled Manner, Excessive Flows Through Blood Vessels Or Stent-Grafts While Maintaining Patency
  Presenter(s):Jerry Matteo, MD  
  View Slides in PDF      
5:42 PM - 5:47 PM Best Current Bridging Treatment For Anticoagulated Patients Requiring Vascular Surgery
  Presenter(s):Don Poldermans, MD  
  View Slides in PDF      
5:48 PM - 5:58 PM Panel Discussion

End of Program J


END OF SESSION 78
 
SESSION 79 SCHEDULE
Friday
SESSION 79: NEW DEVELOPMENTS IN THE TREATMENT OF ANEURYSMS AND OTHER DISEASES INVOLVING THE POPLITEAL ARTERY
x
POPLITEAL ANEURYSMS
6:40 AM - 6:45 AM Why Do We Still Need Open Surgery For Some Popliteal Aneurysms: What Are The Indications – Relative And Absolute
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
  View Slides in PDF      
6:46 AM - 6:51 AM Comparison Of Open And Endo Popliteal Aneurysms Repair In The Same Patients
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM DEBATE: Endovascular Repair Of Popliteal Aneurysms Is Less Risky Than Open Repair And Should Be The Procedure Of Choice: What Percent Of Patients Should Be Treated Endo
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Slides in PDF      
6:58 AM - 7:03 AM DEBATE: Not So: Open Repair Is Better For Most Popliteal Aneurysm Patients: Endo Repair Is Sometimes A Failed Experiment
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
7:04 AM - 7:09 AM How Should Giant Popliteal Aneurysms Be Treated: Open vs. Endo And Tips And Tricks
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM Duplex Guided Endovascular Repair Of Popliteal Aneurysms: Why It Is A Better Way
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD / Anil P. Hingorani, MD  
  View Slides in PDF      
POPLITEAL ENTRAPMENT SYNDROMES
7:16 AM - 7:21 AM New Developments In And Present Status Of Diagnosis And Treatment For Popliteal Entrapment Syndromes
  Presenter(s):Niten Singh, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM When Should Patients With Popliteal Arterial Compression Be Treated By PTA Plus Surgical Decompression: Long-Term (10-Year) Results Show It Is Sometimes The Better Treatment
  Presenter(s):Beatrice R. Amann-Vesti, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM Why Flexed Knee Angiography Should Always Be Performed To Control All Popliteal Interventions Or Procedures
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
7:34 AM - 7:40 AM Panel Discussion
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: INFECTED ARTERIES AND ARTERIAL GRAFTS AND THEIR TREATMENT: INFECTED EVARs; MYCOTIC AAAs; INFECTED AORTIC/ARTERIAL PROSTHETIC GRAFTS; TREATMENT OF AORTO-ESOPHAGEAL FISTULA
x
MANAGEMENT OF INFECTED EVARS
7:40 AM - 7:45 AM DEBATE: Update On Treatment Of Infected Aortic Endografts: Open Surgical Graft Excision Is Always Indicated
  Presenter(s):Kamphol Laohapensang, MD  
  View Slides in PDF      
7:46 AM - 7:51 AM DEBATE: Not So: Semi-Conservative Treatment Without Graft Excision And With Drainage And Antibiotic Irrigation Of AAA Sac Can Be Effective Treatment: Longer-Term Results Prove It
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
7:52 AM - 7:57 AM Treatment Of Infected Abdominal Endografts: Radical vs. Conservative: Late Survival Results With Each Treatment – From A Multicenter Study
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
TREATMENT OF MYCOTIC AAAS
7:58 AM - 8:03 AM Long-Term Outcome Of EVAR Treatment For Mycotic AAAs: What Risk Factors Impact On Late Survival
  Presenter(s):I-Hui Wu, MD, PhD  
  View Slides in PDF      
8:04 AM - 8:09 AM When Aortic Infections And Mycotic AAAs Are Treated By EVAR, Early Success Does Not Equal Late Success: The Infection Returns: What To Do About It
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
8:10 AM - 8:15 AM For Mycotic AAAs What Is The Value Of Endovascular Techniques And EVAR: When Are They Temporary Solutions And When Durable Treatment
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Value Of Vein Graft Covered Stent For Treatment Of Mycotic AAAs: Technique And Results
  Presenter(s):Klaus M. Overbeck, MD, MPhil  
  View Slides in PDF      
8:22 AM - 8:28 AM Panel Discussion
TREATMENT OF AORTIC GRAFT INFECTION
Moderator(s): Thomas C. Bower, MD / Keith D. Calligaro, MD  
8:28 AM - 8:33 AM Intra-Abdominal Extra-Anatomic Reconstruction For Suprarenal Aortic And Graft Infection: Techniques And Results
  Presenter(s):Manju Kalra, MBBS / Thomas C. Bower, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Current Status Of Treatment For Aortic Graft Infection: When Should Cryopreserved Allografts Be Used And When Not: How Well Do They Work Long-Term
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM New Developments In The Treatment Of Prosthetic Aortic Graft Infection Facilitate In Situ Repair: Negative Pressure Wound Therapy And Bovine Pericardium Vascular Grafts: Techniques And Results
  Presenter(s):Max Zegelman, MD  
  View Slides in PDF      
8:46 AM - 8:51 AM Good Early Results Of Negative Pressure Wound Non-Excisional Treatment For Prosthetic Graft Infection Are Durable: It Is A Game Changer: Techniques And Long-Term Results
  Presenter(s):Dieter O. Mayer, MD / Barbara Hasse, MD / Mario L. Lachat, MD / Zoran Rancic, MD, PhD  
  View Slides in PDF      
8:52 AM - 8:57 AM Treatment Of Unilateral Limb Infection Of An Aortobifemoral Prosthetic Graft: Single Limb Excision Is Effective In ~50% Of Cases: When Should It Be Attempted: Diagnosis And Techniques
  Presenter(s):Gregory L. Moneta, MD  
  View Slides in PDF      
THORACIC GRAFT INFECTIONS
8:58 AM - 9:03 AM How Best To Treat Infectious Complications Of Open And Endo Thoracic Aortic Repairs
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM Treatment Of Post-TEVAR Aorto-Esophageal Fistula: Only Radical Surgery Can Be Effective: Techniques And Sequence Of Treatment
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
9:10 AM - 9:16 AM Panel Discussion
9:16 AM - 9:24 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: ADVANCES IN IMAGING, GUIDANCE AND HYBRID SUITES/ORs
x
9:24 AM - 9:29 AM What Vascular Surgeons Need To Know About Peripheral CT Angiography (CTA) And MR Angiography (MRA) To Make Them Most Valuable For Vascular Decision Making
  Presenter(s):Michael H. Wholey, MD, MBA  
  View Slides in PDF      
9:30 AM - 9:35 AM 3D Live Interactive Holography For Vascular Interventions: Advantages And Limitations
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
ADVANCED RADIOGRAPHIC IMAGING: FUSION AND DYNA-CT
9:36 AM - 9:41 AM Principles Of Fusion Techniques And Dyna-CT: Advantages And Limitations During EVAR And TEVAR
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
9:42 AM - 9:47 AM DEBATE: Hybrid Rooms With Fixed Fluoroscopy Units, Fusion And Dyna-CT Are Essential For Complex EVAR Procedures (F/BEVAR)
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
9:48 AM - 9:53 AM DEBATE: Not So: Results With Complex EVARs (F/BEVAR) Performed With C-Arm Mobile Imaging Fluoroscopy Units Are As Good As Those Done With Fixed Equipment In A Hybrid Suite
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Slides in PDF      
9:54 AM - 9:59 AM Advantages Of The Ziehm Vision RFD Hybrid Mobile Motorized C-Arm And Stille ImagiQ2 Floating Table: How Do They Compare With Fixed Hybrid Equipment For Complex Aortic Procedures
  Presenter(s):Peter C.J. Goverde, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM 3D Fusion Is Possible With Any Digital C-Arm Mobile Fluoroscope Using The Cydar Software System: How It Works And Can Simplify And Improve Fusion Techniques
  Presenter(s):Tom Carrell, MD, MChir / Cynthia K. Shortell, MD  
  View Slides in PDF      
10:06 AM - 10:12 AM Panel Discussion
WHAT IS ON THE HORIZON WITH IMAGING
Moderator(s): Frans L. Moll, MD, PhD / Daniel G. Clair, MD  
10:12 AM - 10:17 AM New Developments In Imaging That Are On The Horizon And That Will Change Our Management Of Most Complex Vascular Interventional Treatments
  Presenter(s):Lieven F. Maene, MD  
  View Slides in PDF      
10:18 AM - 10:23 AM The Future Of Vascular Imaging And Guidance: Where Are They Going
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
10:24 AM - 10:29 AM DEBATE: Ultrasound Imaging And Guidance Are The Best Method To Control Retrograde Distal Access Procedures And Crossing CTOs: Tips And Tricks
  Presenter(s):Constantino Pena, MD / Jihad A. Mustapha, MD  
  View Slides in PDF      
10:30 AM - 10:35 AM DEBATE: Not So: Fluoroscopy And Angiography Are The Best Way To Control Distal Puncture Procedures And Lesion Crossing: Technical Tips And Tricks
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
10:36 AM - 10:41 AM Advanced Imaging Tools (The Vessel Assist System From GE) Can Improve 3D Imaging And Fusion And Facilitate Lower Extremity And CAS Procedures
  Presenter(s):Koen Deloose, MD  
  View Slides in PDF      
10:42 AM - 10:47 AM Why IVUS Use Should Become Standard Of Care In An Endovascular Practice: In What Procedures Is It A Must
  Presenter(s):Donald B. Reid, MD  
  View Slides in PDF      
10:48 AM - 10:53 AM Update On Strategies To Reduce Contrast Induced Nephropathy: What Works And What Doesn’t
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
10:54 AM - 11:00 AM Panel Discussion
END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs) AND CARDIAC EVALUATION
x
ADVANCES IN NEUROGENIC TOS
11:00 AM - 11:05 AM New Objective Outcomes Reporting For Neurogenic TOS
  Presenter(s):Karl A. Illig, MD  
  View Slides in PDF      
11:06 AM - 11:11 AM Neurogenic TOS In Competitive Athletes: Is It Real: How Is It Best Diagnosed And Managed
  Presenter(s):Michael J. Singh, MD  
  View Slides in PDF      
11:12 AM - 11:17 AM Diagnosis And Optimal Treatment For Neurogenic TOS: The Supraclavicular Approach For First Rib Resection Is Best: How To Do It Well
  Presenter(s):Robert W. Thompson, MD  
  View Slides in PDF      
11:18 AM - 11:23 AM What Comprises TOS Specific Physical Therapy And How Often Is It Effective In Neurogenic TOS
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM Robot Assisted Thoroscopic Minimally Invasive Treatment Of TOS Including First Rib Resection: How Is It Done (Video), Advantages And Limitations
  Presenter(s):Hans M.E. Coveliers, MD, PhD, MBA  
  View Slides in PDF      
TREATMENT OF VENOUS TOS
11:30 AM - 11:35 AM Optimal Way To Diagnose And Treat Venous TOS With Axillary-Subclavian Vein Thrombosis: Both The Supraclavicular And Infraclavicular Approaches Are Needed For Vein Exposure And Reconstruction
  Presenter(s):Robert W. Thompson, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM Tips And Tricks For Transaxillary First Rib Resection For Venous TOS: The Subclavian Vein Seldom If Ever Needs To Be Surgically Reconstructed
  Presenter(s):Benjamin M. Jackson, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM Infraclavicular Approaches To Venous TOS: Technique, Advantages And Limitation: What Can Be Done If The Subclavian Vein Needs To Be Reconstructed Or Cleaned Out
  Presenter(s):Joseph J. Ricotta II, MD, MS  
  View Slides in PDF      
PRE-OP CARDIAC EVALUATION
11:48 AM - 11:53 AM Are Cardiology Evaluations Of Any Value Before Vascular Operations: What Is Of Value: Current State Of The Art
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: NEW OR UPDATED CONCEPTS AND TREATMENTS FOR VASCULAR TRAUMA AND TAKAYASU’S DISEASE; MEDICAL TOPICS AND TREATMENTS
x
1:00 PM - 1:05 PM How To Reduce Door-To-Reperfusion Time With Severe Arterial Trauma
  Presenter(s):Markus K. Furrer, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM New Developments In Endovascular Treatment And Balloon Occlusion For Major Arterial Trauma: What Is REBOA And Does Partial Aortic Balloon Occlusion Have Value
  Presenter(s):Tal M. Hörer, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA) For Trauma Or Ruptured AAA: Is There A Role For IVUS Guidance To Facilitate Placement By Non-Interventionalists
  Presenter(s):Donald L. Jacobs, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Update On An Improved Classification System, TEVAR Devices And Techniques For Blunt Thoracic Aortic Injury (BTAI)
  Presenter(s):Ali Azizzadeh, MD / Benjamin W. Starnes, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Indications For Early Non-Operative Treatment With BTAI: It Is Safe And Lowers Mortality In Selected Patients: Indications For Early TEVAR
  Presenter(s):Robert S. Crawford, MD / Donald G. Harris, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Endovascular Treatment Of Traumatic Aortic Rupture In Children: What Devices Can Be Used For TEVAR
  Presenter(s):Gabriel Szendro, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Tips And Tricks For Recognizing And Treating Acute Popliteal Artery Injuries (Lacerations And Occlusions) After Orthopedic Knee Surgery: They Are Often Missed
  Presenter(s):Sohail Khan, MD  
  View Slides in PDF      
TAKAYASU’S DISEASE
1:42 PM - 1:47 PM Bypasses vs. Endovascular Treatments For Symptomatic Takayasu’s Arteritis: Pros And Cons Of Each
  Presenter(s):Byung-Boong Lee, MD  
  View Slides in PDF      
OTHER TOPICS
1:48 PM - 1:53 PM Current Management Strategies For Ehlers Danlos Syndrome And Role Of Endografts In The Treatment Of Its Arterial Lesions
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Preop Non-Invasive Fractional Flow Reserve (FFR) Evaluation Of Coronary Lesion Can Improve Care And Decrease Costs In Vascular Patients: Technique And Results
  Presenter(s):Tej M. Singh, MD, MBA  
  View Slides in PDF      
2:00 PM - 2:08 PM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: NEW DEVELOPMENTS AND UPDATES REGARDING CCSVI IN MULTIPLE SCLEROSIS; USE OF DRUGS IN VASCULAR DISEASE PATIENTS AND WAYS TO PREDICT RISKS OF ADVERSE EVENTS
x
CCSVI
2:08 PM - 2:13 PM Multicenter Blinded RCT To Determine Safety And Effectiveness (Quality Of Life) Of Venous PTA For Multiple Sclerosis (The BRAVE DREAMS Trial): Design And Progress: Will It Settle The Controversy
  Presenter(s):Paolo Zamboni, MD  
  View Slides in PDF      
DRUG TREATMENT OF VASCULAR DISEASES
2:14 PM - 2:19 PM How Can Statins And Other Medical Treatment Decrease The Amputation And Major Adverse Limb Event Rates After Revascularizations For CLI: What Are The Optimal Drugs And Dosages
  Presenter(s):Patrick A. Stone, MD / Aravinda Nanjundappa, MD  
  View Slides in PDF      
2:20 PM - 2:25 PM Optimal Use Of ACE Inhibitors, Cilostazol, And Statins In Patients Undergoing Open And Endovascular Procedures
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
2:26 PM - 2:31 PM Update On When And How Should Beta Blockers Be Used In Low Risk And High Risk Vascular Patients Generally And When They Undergo Operations And Interventions: Dosage Is Key
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
2:32 PM - 2:37 PM Improving Non-Coronary Stent Outcomes By Pharmacological Manipulations – 2C19 And Plavix: How Do They Do It
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Slides in PDF      
2:38 PM - 2:43 PM What Is New In Antiplatelet Treatment Of Vascular Patients: Which Drugs In Which Situation: New Drugs And What Does The EUCLID Trial Tell Us
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC  / Caron B. Rockman, MD  
  View Slides in PDF      
2:44 PM - 2:50 PM Panel Discussion
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Elliot L. Chaikof, MD, PhD  
2:50 PM - 2:55 PM Benefits Of Perioperative Statins In Improving Outcomes And Decreasing Adverse Events After AAA And Carotid Procedures – Endo And Open: Optimal Timing, Drug And Dosage
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
2:56 PM - 3:01 PM Update On The Medical (Drug) Treatment Of AAA Disease: What Does Metformin Do: Does Any Drug Slow AAA Growth
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
3:02 PM - 3:07 PM Should Bivalirudin Replace Heparin In Non-Cardiac Interventions: Advantages And How To Use It
  Presenter(s):George H. Meier III, MD  
  View Slides in PDF      
VALUE OF TESTS
3:08 PM - 3:13 PM Biomarkers Can Predict Long-Term (~10 Years) Adverse Cardiovascular Events In Vascular Patients: Which Ones And How Can They Be Used
  Presenter(s):Beatrice R. Amann-Vesti, MD  
  View Slides in PDF      
3:14 PM - 3:19 PM How To Identify Patients At Risk Of Cardiovascular Adverse Events After EVAR
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
3:20 PM - 3:26 PM Panel Discussion
3:26 PM - 3:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: NEW CONCEPTS AND TECHNIQUES TO DECREASE RADIATION EXPOSURE FOR ENDOVASCULAR SURGEONS/SPECIALISTS AND PATIENTS
x
3:36 PM - 3:41 PM Crucial Elements In Radiation Safety For Non-Radiology Interventionists: Advice From A Radiologist
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
3:42 PM - 3:47 PM Comparison Of Radiation Dosage And Safety Between Mobile C-Arm Fluoroscopes And Fixed Hybrid Units
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
3:48 PM - 3:53 PM What Part Of Interventional Physicians Are At Risk From Radiation And Is Protective Gear Really Protective: Light Weight Lead Aprons Are A Hoax
  Presenter(s):Lindsay Machan, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM How To Minimize Radiation Exposure During Complex Endovascular AAA Repairs: Tips And Tricks
  Presenter(s):Neal S. Cayne, MD  
  View Slides in PDF      
4:00 PM - 4:05 PM New Processing Software And Other Techniques For Reducing Radiation Exposure During Complex Interventional Procedures
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
4:06 PM - 4:11 PM How OCT (Optical Coherence Tomography) Imaging Can Control Crossing Of CTOs And Decrease Radiation Exposure: So Too Can Expanded Use Of Duplex And IVUS
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
4:12 PM - 4:17 PM Worrisome Biologic And Dosimetric Effects Of Operator Radiation Exposure During Complex Interventional Procedures: How Can They Be Measured And Decreased
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
4:18 PM - 4:23 PM Malignancies Occurring During CT Follow-Up Of EVAR: It Is A Real Risk And What To Do About It
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
4:24 PM - 4:32 PM Panel Discussion
END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: RECORDED LIVE CASES OF COMPLEX AORTIC ANEURYSM TREATMENT WITH ENDOVASCULAR TECHNIQUES
x
4:32 PM - 4:52 PM Complex Cases From Münster
  Presenter(s):Giovanni Torsello, MD  
  View Slides in PDF      
4:52 PM - 5:02 PM Questions And Discussion
5:03 PM - 5:23 PM Complex Cases From The Mayo Clinic – Including Use Of A 3D Model With Pump Perfusion (Sande Stabile) For Planning And Simulation
  Presenter(s):Gustavo S. Oderich, MD FACS  
  View Slides in PDF      
5:23 PM - 5:35 PM Questions And Discussion

End of Program K


END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: VENOUS CROSS-SECTIONAL IMAGING TECHNIQUES, PELVIC VENOUS DISORDERS
x
6:58 AM - 6:59 AM Introduction To Deep Veins
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
7:00 AM - 7:05 AM Evaluation Of The Severity Of Venous Obstruction
  Presenter(s):Olivier Hartung, MD  
  View Slides in PDF      
7:06 AM - 7:11 AM Getting A Look At Inflow With Duplex Ultrasound Prior To Endovascular Reconstruction Of Post-Thrombotic Iliocaval Disease
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
7:12 AM - 7:17 AM How To Measure Iliac Vein Stenosis
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
7:18 AM - 7:23 AM Pertinent IVUS Anatomy
  Presenter(s):Paul J. Gagne, MD  
  View Slides in PDF      
7:24 AM - 7:29 AM Novel Imaging Techniques With MRI For Thrombus Aging
  Presenter(s):Stephen A. Black, MD  
  View Slides in PDF      
7:30 AM - 7:35 AM The Bull’s-Eye Sign And Other Iliocaval-Femoral Venographic Findings: A New Classification To Limit The Use Of Intravascular Ultrasound
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
7:36 AM - 7:41 AM A New Look At Venous Hemodynamics: Measuring Reflux And Venous Outflow Obstruction
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
7:42 AM - 7:47 AM MRV And Major Venous Interventions
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
7:48 AM - 7:53 AM MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Syndromes: Which Is Better And Why
  Presenter(s):Constantino Pena, MD  
  View Slides in PDF      
7:54 AM - 7:58 AM Panel Discussion
PELVIC VENOUS DISORDERS
7:59 AM - 8:04 AM Reasons New Nomenclature Is Needed For Pelvic Venous Disorders
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
8:05 AM - 8:10 AM Pelvic Venous Incompetence And Leg Varicosities: Start From Above Or Below
  Presenter(s):Melvin Rosenblatt, MD  
  View Slides in PDF      
8:11 AM - 8:16 AM Pelvic Varices Are Best Studied With Trans-Vaginal Duplex Ultrasound
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
8:17 AM - 8:22 AM Venographic Technique To Identify Pelvic Anatomy And Escape Points
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
8:23 AM - 8:28 AM Ovarian Vein Incompetence Or Renal Vein Compression
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
8:29 AM - 8:34 AM Acute Or Chronic Ovarian Vein Thrombosis: What To Do
  Presenter(s):Mikel Sadek, MD  
  View Slides in PDF      
8:35 AM - 8:40 AM DEBATE: Renal Vein Transposition (With Patch) Is The Ideal Treatment For Nutcracker Syndrome, Not Stenting
  Presenter(s):Olivier Hartung, MD  
  View Slides in PDF      
8:41 AM - 8:46 AM DEBATE: Gonadal Vein Transposition Is The Ideal Treatment For Nutcracker Syndrome
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
8:47 AM - 8:52 AM DEBATE: Stenting Is The Ideal Treatment For Nutcracker Syndrome
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
8:53 AM - 8:58 AM DEBATE: Hybrid Endo-Open Surgery Is The Ideal Treatment For Nutcracker Syndrome
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
8:59 AM - 9:04 AM Panel Discussion
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
x
9:05 AM - 9:10 AM Exactly What Is The Tissue Causing Post-Thrombotic Venous Obstruction
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
9:11 AM - 9:16 AM DEBATE: Open Excisional Surgery For Post-Thrombotic Common Femoral Vein Obstruction (Endophlebectomy) Is Of Limited Value In the Endovascular Era
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
9:17 AM - 9:22 AM DEBATE: Open Excisional Surgery For Post-Thrombotic Common Femoral Vein Obstruction (Endophlebectomy) Is Standard Of Care
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Slides in PDF      
9:23 AM - 9:28 AM Step By Step Endophlebectomy Of Common Femoral Vein
  Presenter(s):Marzia Lugli, MD  
  View Slides in PDF      
9:29 AM - 9:34 AM Surgical Reconstruction Of Deep Veins: Do I Do It To Improve Inflow Of Obstructive Disease Or To Control Reflux
  Presenter(s):Stephen A. Black, MD  
  View Slides in PDF      
STENTS AND STENT TRIALS
9:35 AM - 9:40 AM Engineering Challenges Required For An Ideal Ilio-Caval Stent
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
9:41 AM - 9:46 AM Dedicated Venous Stents Make Sense
  Presenter(s):Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
9:47 AM - 9:52 AM Results With Dedicated Venous Self-Expanding Oblique Hybrid Nitinol Stent
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
9:53 AM - 9:58 AM Vernacular (Venovo) Stent Trial And Methodology
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
9:59 AM - 10:04 AM An Update On VIVO-EU: The Zilver Vena Venous Stent Study In Europe
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Slides in PDF      
10:05 AM - 10:10 AM VIRTUS - 12-Month Results: VICI Venous Stent – Feasibility Study
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:11 AM - 10:16 AM The Modena Iliac Vein Stent Experience
  Presenter(s):Marzia Lugli, MD  
  View Slides in PDF      
OFF-LABEL STENT USE
10:17 AM - 10:22 AM Crossing Femoro-Iliocaval Chronic Total Occlusions: From Soft Wires To Sharp Harpoons
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
10:23 AM - 10:28 AM DEBATE: Femoral Vein Stenting Succeeds Under These Conditions
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM DEBATE: Femoral Vein Stenting Fails Often And Early
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
10:35 AM - 10:40 AM DEBATE: Femoral Vein Angioplasty (Not Stents): Must Look And Treat Popliteal Vein And Below To Succeed Often
  Presenter(s):Mark J. Garcia, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM Panel Discussion
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION; WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
x
10:47 AM - 10:52 AM Years Of Planning Venous Stents: What I Have Learned
  Presenter(s):Olivier Hartung, MD  
  View Slides in PDF      
10:53 AM - 10:58 AM Z-Stent Extension Into The Cava: Reduces Contralateral Iliac Vein Thrombosis: Short Term Data
  Presenter(s):Erin H. Murphy, MD  
  View Slides in PDF      
10:59 AM - 11:04 AM Step By Step Deep Venous Valve Repair Or Creation
  Presenter(s):Marzia Lugli, MD / Oscar Maleti, MD  
  View Slides in PDF      
11:05 AM - 11:10 AM Deep Venous Reflux Reconstruction Techniques
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
11:11 AM - 11:16 AM Deep Venous Obstruction Reconstructive Techniques
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
WOUNDS AND NEW HORIZONS
11:17 AM - 11:22 AM Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures
  Presenter(s):Marc A. Passman, MD  
  View Slides in PDF      
11:23 AM - 11:28 AM RCT Demonstrating Benefits Of Sulodexide For Venous Ulcers
  Presenter(s):Joseph D. Raffetto, MD  
  View Slides in PDF      
11:29 AM - 11:34 AM Important RCTs For Venous Wound Healing
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
11:35 AM - 11:40 AM Surgical Intervention On Venous Ulcer Based On Cost-Effectiveness: Is It Different Than C2
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
11:41 AM - 11:46 AM Proteomics And Degradomics In Venous Leg Ulcers
  Presenter(s):Joseph D. Raffetto, MD  
  View Slides in PDF      
11:47 AM - 11:52 AM Not All Leg Ulcers Are Venous
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
11:53 AM - 11:59 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO SUBCLAVIAN SYSTEM
x
VENOUS THROMBOEMBOLISM (VTE) MEDICAL
1:00 PM - 1:05 PM Experimental Insights Into Acute DVT And Post-Thrombotic Syndrome (PTS)
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Calf Muscle Compartment Pressure In Acute Iliofemoral DVT And The Effect Of Early Thrombus Removal
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Update On Reversal Agents For The Direct Oral Anticoagulants (DOACs)
  Presenter(s):Timothy K. Liem, MD, MBA  
  View Slides in PDF      
1:18 PM - 1:23 PM Isolated Soleal And Gastrocnemius Vein Thrombosis
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
  View Slides in PDF      
1:24 PM - 1:29 PM Popliteal Venous Entrapment: When And What Do You Do
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
1:30 PM - 1:35 PM Biomarkers Of Venous Thromboembolism: Do They Have A Current Role
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM What Is The True Incidence Of PE In Patients With Ilio-Femoral DVT: How Many Of These Have Right Ventricular Strain
  Presenter(s):Divya Sridhar, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Which DOAC For Which DVT: Can We Stratify Yet
  Presenter(s):Timothy K. Liem, MD, MBA  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
VTE-INTERVENTIONAL
Moderator(s): Brian G. DeRubertis, MD / Suresh Vedantham, MD  
1:55 PM - 2:00 PM Technical Considerations And Emerging Technology For Chronic Venous Occlusions
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
2:01 PM - 2:06 PM What Is The Best Method To Measure Venous Thrombolysis Resolution
  Presenter(s):Akhilesh K. Sista, MD  
  View Slides in PDF      
2:07 PM - 2:12 PM If The ATTRACT Trial Is Positive What Will Happen In US/Europe/Asia
  Presenter(s):Suresh Vedantham, MD  
  View Slides in PDF      
2:13 PM - 2:18 PM Prevention Of PTS: Is The Jury Still Out: Statins And VTE
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
2:19 PM - 2:23 PM D-Dimer And/Or Duplex Findings To Manage DVT
  Presenter(s):Timothy K. Liem, MD, MBA  
  View Slides in PDF      
2:24 PM - 2:29 PM Impact Of Caval Occlusion On The Outcomes Of Thrombolysis For Iliofemoral DVT
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Vacuum-Assisted Venous Thrombectomy: Where, When, And How
  Presenter(s):Mikel Sadek, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM An Algorithm For The Treatment Of Paget-Schroetter’s Syndrome
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM QOL After Deep Venous Recanalization Procedures: Any Relation To Patency
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting
  Presenter(s):Enrique Criado, MD, FACS  
  View Slides in PDF      
2:54 PM - 2:59 PM Evolution Of Venous In-Stent Stenosis: Do Anti-Platelet Agents Help Mitigate
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Treating Venous Thromboembolism Without Lytic Medications
  Presenter(s):Constantino Pena, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM Panel Discussion
END OF SESSION 90
 
SESSION 91 SCHEDULE
Friday
SESSION 91: ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
x
MORE FEMORAL-ILIOCAVAL FLOW ISSUES
3:12 PM - 3:17 PM IVC Agenesis – Is This A Real Entity
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
3:18 PM - 3:23 PM IVC Occlusion – Where To Reroute
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
3:24 PM - 3:29 PM Benign And Malignant Caval Tumors
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
3:30 PM - 3:35 PM Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
3:36 PM - 3:41 PM IVC Replacement For Malignancy: How To Do It
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
3:42 PM - 3:47 PM Conduit Choices For In-Line Caval Reconstruction
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
3:48 PM - 3:53 PM Robotic Vena Cava Surgery
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
3:54 PM - 3:59 PM Panel Discussion
CAVAL INTERRUPTION
Moderator(s): John E. Rectenwald, MD, MS / David L. Gillespie, MD  
4:00 PM - 4:05 PM Indications For IVC Filters: Are They Being Observed
  Presenter(s):John E. Rectenwald, MD, MS  
  View Slides in PDF      
4:06 PM - 4:11 PM Update On The Sentry Bioconvertible Non-Retrieval IVC Filter
  Presenter(s):David Rosenthal, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM IVC Filter Retrieval Rates: The Influence Of Filter Design, Practice Administration And The Operator
  Presenter(s):David L. Gillespie, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM The PREPIC Trial: Fact Or Fiction
  Presenter(s):John E. Rectenwald, MD, MS  
  View Slides in PDF      
4:24 PM - 4:29 PM Update On The PRESERVE Vena Cava Filter Study
  Presenter(s):David L. Gillespie, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Ulcer Healing And Quality Of Life Outcomes After Endovascular Iliocaval Reconstruction (Stenting) In Patients With Concomitant IVC And Iliac Occlusive Disease
  Presenter(s):Steven D. Abramowitz, MD / Edward Y. Woo, MD  
  View Slides in PDF      
4:36 PM - 4:41 PM Major Complications After IVC Filter Placement And How To Avoid Them
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
  View Slides in PDF      
4:42 PM - 4:47 PM Difficult Caval Filter Retrieval: Tips And Tools
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
4:48 PM - 4:53 PM What To Do With Fractured Filters And Embolic Filter Fragments
  Presenter(s):Constantino Pena, MD  
  View Slides in PDF      
4:54 PM - 5:00 PM Which Bariatric Surgery Patients Benefit From Prophylactic Caval Filtration
  Presenter(s):Nicholas J. Gargiulo III, MD, RVT, RPVI, RDMS, FACS  
  View Slides in PDF      
5:01 PM - 5:12 PM Panel Discussion

End of Program L


END OF SESSION 91
 
SESSION 92 SCHEDULE
Friday
SESSION 92: INTRODUCTION TO VASCULAR MALFORMATIONS
x
6:45 AM - 6:50 AM Welcome
  Presenter(s):Krassi Ivancev, MD, PhD  
6:50 AM - 7:00 AM The ISSVA Vascular Anomalies Classification System
  Presenter(s):Leo J. Schultze Kool, MD, PhD  
  View Slides in PDF      
7:00 AM - 7:10 AM MR Imaging And MR Guided Treatment Techniques Of Congenital Vascular Malformations
  Presenter(s):R. Sean Pakbaz, MD  
7:10 AM - 7:20 AM Techniques And Considerations For Endovascular Access And Embolization Procedures In A Specialized Population: Neonates And Children
  Presenter(s):James Donaldson, MD  
  View Slides in PDF      
7:20 AM - 7:30 AM The Yakes AVM Classification System And Its Therapeutic Implications In Challenging Cases
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
END OF SESSION 92
 
SESSION 93 SCHEDULE
Friday
SESSION 93: HIGH FLOW VASCULAR MALFORMATION MANAGEMENT STRATEGIES
x
7:30 AM - 7:40 AM Tips And Tricks For nBCA AVM Embolization: Long-Term Patient Outcomes And Complications: The Lenox Hill Heart & Vascular Institute of New York Experience
  Presenter(s):Robert J. Rosen, MD  
  View Slides in PDF      
7:40 AM - 7:50 AM Extracranial To Intracranial Dangerous Arterial Anastomoses: Important Considerations In Endovascular Management Of Head & Neck AVMs
  Presenter(s):R. Sean Pakbaz, MD  
7:50 AM - 8:00 AM nBCA And Ethanol Endovascular Techniques Used For Complex AVM Treatment Strategies: The San Diego Vascular Malformation Experience
  Presenter(s):R. Sean Pakbaz, MD  
8:00 AM - 8:10 AM Tips And Tricks Of Complex Peripheral AVM Endovascular Treatment With Onyx: The University of Istanbul Medical Center Experience
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
8:10 AM - 8:20 AM Onyx AVM Embolotherapy: Detailed Histologic Evaluation Of Post-Op Resected Specimens: The University of Arkansas at Little Rock Experience
  Presenter(s):Mollie Meek, MD  
  View Slides in PDF      
8:20 AM - 8:30 AM Odyssey From Onyx To Ethanol In AVM Endovascular Treatment: The University of Warsaw Medical Center Experience
  Presenter(s):Mikolaj Wojtaszek, MD, PhD  
  View Slides in PDF      
8:30 AM - 8:40 AM Use Of A New AVM Classification System To Treat High-Flow Vascular Malformations At The University of Olomouc Medical Center: The Czech Experience
  Presenter(s):Martin Koecher, MD  
  View Slides in PDF      
8:40 AM - 8:50 AM Salvage Endovascular Procedures For Onyx AVM Treatment Failures: A Worldwide Experience
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
DEBATE: PALLIATIVE POLYMERIZING AGENTS VS. CURATIVE ETHANOL/COILS APPROACHES: WHICH IS BEST
8:50 AM - 8:55 AM The Best Management For AVMs Is Done With Polymerizing Agents (NBCA, Onyx)
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
8:55 AM - 9:00 AM The Best Management For AVMs Is Done With Polymerizing Agents (NBCA, Onyx)
  Presenter(s):Robert J. Rosen, MD  
  View Slides in PDF      
9:00 AM - 9:05 AM The Best Management For AVMs Is Done With Ethanol, And In Yakes Type I/IIIa/IIIb AVMs With Coils/Ethanol
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
9:05 AM - 9:10 AM The Best Management For AVMs With Ethanol And/Or Coils By SMC Classification
  Presenter(s):Young Soo Do, MD, PhD  
  View Slides in PDF      
9:10 AM - 9:20 AM Audience Questions For The Panel
END OF SESSION 93
 
SESSION 94 SCHEDULE
Friday
SESSION 94: LOW FLOW VASCULAR MALFORMATION MANAGEMENT
x
9:20 AM - 9:30 AM Use Of Sotradecol, Foam, And Other Sclerosants: Long-Term Follow-Up And Complications In A Pediatric Population: The Ann & Robert H. Lurie Children’s Hospital Experience In Chicago
  Presenter(s):James Donaldson, MD  
  View Slides in PDF      
9:30 AM - 9:40 AM Comparative Use Of Bleomycin And Ethanol In Low-Flow Vascular Malformations Treatment In Multiple Anatomies At The Ninth People’s Hospital: The Shanghai Experience
  Presenter(s):Xindong Fan, MD  
  View Slides in PDF      
9:40 AM - 9:50 AM Techniques And Sclerosants For Venous And Lymphatic Malformation Treatment At The St. Radboud University Medical Center: The Dutch Experience
  Presenter(s):Leo J. Schultze Kool, MD, PhD  
  View Slides in PDF      
9:50 AM - 10:00 AM The Interventional Radiologist’s Role In The Klippel-Trenaunay & Parkes – Weber Syndromes And Other Tissue Overgrowth Disorders: The Emory University Medical Center Experience In Atlanta
  Presenter(s):Louis G. Martin, MD  
  View Slides in PDF      
10:00 AM - 10:10 AM Complex Low-Flow Vascular Malformations And The Journal Reports Of Multiple Sclerosant Agents: A World In Endovascular Confusion And Chaos
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
10:10 AM - 10:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 94
 
SESSION 95 SCHEDULE
Friday
SESSION 95: SURGERY IN VASCULAR MALFORMATION MANAGEMENT
Moderators:Jia Wei Zheng, PhD / Dong-ik Kim, MD  
x
10:30 AM - 10:40 AM Surgical Approaches To Vascular Malformation Management: Triumphs And Pitfalls
  Presenter(s):Christopher J. Morin , MD  
  View Slides in PDF      
10:40 AM - 10:50 AM Combined Endovascular And Surgical Management Strategies In Complex Vascular Malformation Treatment At The Samsung Medical Center: The Seoul Experience
  Presenter(s):Dong-ik Kim, MD  
  View Slides in PDF      
10:50 AM - 11:00 AM Reconstructive Surgical Issues With Complex Vascular Malformations
  Presenter(s):Tanya M. Oswald, MD  
  View Slides in PDF      
11:00 AM - 11:10 AM Surgical Strategies For Lymphatic Malformations At The Ninth People’s Hospital: The Shanghai Experience
  Presenter(s):Jia Wei Zheng, PhD  
11:10 AM - 11:20 AM Surgical Reconstructions And Patient Normalization Post-Endovascular Ablation Of Head & Neck Vascular Malformations
  Presenter(s):Randolph C. Robinson, MD, DDS  
  View Slides in PDF      
END OF SESSION 95
 
SESSION 96 SCHEDULE
Friday
SESSION 96: AVM COMPLICATIONS WE ALL ENCOUNTER - IF YOU ARE DOING AVM CASES, THESE WILL OCCUR - LET US LEARN TOGETHER FOR OUR PATIENTS’ SAKE
x
11:20 AM - 11:25 AM AVM Complications Case Presentation
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
11:25 AM - 11:30 AM AVM Complications Case Presentation
  Presenter(s):Robert J. Rosen, MD  
  View Slides in PDF      
11:30 AM - 11:35 AM AVM Complications Case Presentation
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
11:35 AM - 11:40 AM AVM Complications Case Presentation
  Presenter(s):Louis G. Martin, MD  
  View Slides in PDF      
END OF SESSION 96
 
SESSION 97 SCHEDULE
Friday
SESSION 97: HOW DO I DO THESE CASES RIGHT
x
11:40 AM - 11:45 AM How Do I Determine Where The Damn Nidus Is
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
11:45 AM - 11:50 AM Upper Extremity And Hand AVMs: How I Do It
  Presenter(s):Young Soo Do, MD, PhD  
  View Slides in PDF      
11:50 AM - 11:55 AM How I Treat Plantar Foot AVMs
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
11:55 AM - 12:00 PM How I Treat Pelvic AVMs
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
12:00 PM - 12:10 PM How I Treat Problematic Intraosseous AVMs
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
12:10 PM - 12:20 PM Pick Up Lunch in the South Corridor Exhibit Area (2nd Floor) and Return to the Gramercy Suites for Luncheon Program.
END OF SESSION 97
 
SESSION 98 SCHEDULE
Friday
SESSION 98: COMPLEX AVMs THAT PURPOSEFULLY CONFOUND US
x
12:20 PM - 12:30 PM Curative Endovascular AVM Treatment Techniques Utilizing The Retrograde Vein Approach: The Northwestern Memorial Hospital Experience In Chicago
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
12:30 PM - 12:40 PM Complex AVM Curative Endovascular Treatment At The Samsung Medical Center: The Korean Experience
  Presenter(s):Young Soo Do, MD, PhD  
  View Slides in PDF      
12:40 PM - 12:50 PM The Vascular Malformation International Road Show At The International Medical Center In Cairo And At The Medical University Hospital Of Lubin, Poland
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
12:50 PM - 1:00 PM Curative Treatment Of Challenging Scalp, Ear And Mandible AVMs At The Ninth People’s Hospital: The Shanghai Experience
  Presenter(s):Xindong Fan, MD  
  View Slides in PDF      
1:00 PM - 1:10 PM Complex AVM Endovascular Management Techniques: The University of Arkansas at Little Rock Experience
  Presenter(s):Mollie Meek, MD  
  View Slides in PDF      
1:10 PM - 1:20 PM Endovascular Curative Treatment Strategies Of patients With Multiple Complex AVMs: The Denver Experience
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
1:20 PM - 1:30 PM Panel Discussion (All AVM Faculty)

End of Program M


END OF SESSION 98